Biotech startups that raised Series A in Shenzhen, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Artivila Therapeutics | Shenzhen | Series A | $14.7M | 2026-06-23 |
| Shanmu SHANMU | Shenzhen | Series A | $14.7M | 2026-05-06 |
| Liying Bio | Shenzhen | Series A | $13.7M | 2024-12-31 |
| Baikuirui | Shenzhen | Series A | $1.4M | 2024-04-23 |
| Ceram Pharmaceuticals | Shenzhen | Series A | $14.0M | 2023-12-25 |
| iCarbonX | Shenzhen | Series A | $45.0M | 2016-07-15 |
6 rows of the CSV in 5 of its 18 columns.
- The 34 biotech startups in Shenzhen, China whose last round is Series A have raised $524.8M in total.
- 11 of them closed their most recent round in the last 12 months, $88.6M combined.
- The largest of those rounds is PAM2L Biotechnologies' $30.0M Series A, dated October 2026.
- SZHTI Group is an investor in 2 of them, more than any other fund.
- Health care is the most common other sector, with 26 companies (76%).
- 41% were founded in 2020 or later; the median founding year is 2019.
- The most common team size is 11 to 50 employees (64% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
3 of 34| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| iCarbonX Unicorn | iCarbonX is a China-based company that builds artificial intelligence platforms for health data. | Artificial intelligence | Series A | $45.0M | 2016-07-15 | $200.0M | Share Capital, ProCapital | 51 to 100 | 2015 |
Table 1. Biotech startups that raised Series A in Shenzhen, China: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 34.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| 2 | Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
Table 2. Biotech startups that raised Series A in Shenzhen, China: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | SZHTI Group | Venture capital firm | Shenzhen, China | 2 | 6% | 2 | Newdel Biotech, JGene Biotechnology |
| 2 | Kaitai Capital | Venture capital firm | Hangzhou, China | 2 | 6% | ||
| 3 | Highlight Capital | Private equity firm | Nanjin, China | 1 | 3% | 1 | Artivila Therapeutics |
| 4 | Hike Capital | Private equity firm | Beijing, China | 1 | 3% | 1 | Artivila Therapeutics |
| 5 | Sinopharm Capital | Venture capital firm | Shanghai, China | 1 | 3% | 1 | Artivila Therapeutics |
| 6 | Med-Fine Capital | Venture capital firm | Shanghai, China | 1 | 3% | 1 | Artivila Therapeutics |
| 7 | Yijing Capital | Venture capital firm | Shanghai, China | 1 | 3% | 1 | Artivila Therapeutics |
| 8 | Wanwu Capital | Venture capital firm | Beijing, China | 1 | 3% | 1 | Shanmu SHANMU |
| 9 | Glacier Capital | Investment bank | Phoenix, United States | 1 | 3% | 1 | Shanmu SHANMU |
| 10 | QF Capital | Private equity firm | Shenzhen, China | 1 | 3% | 1 | Shanmu SHANMU |
| 11 | Hofan Venture | Venture capital firm | Shenzhen, China | 1 | 3% | 1 | Shanmu SHANMU |
| 12 | Hecheng Capital | Venture capital firm | Beijing, China | 1 | 3% | 1 | Newdel Biotech |
| 13 | Tianjin Venture Capital | Venture capital firm | Tianjin, China | 1 | 3% | 1 | JGene Biotechnology |
| 14 | EFung Capital | Private equity firm | Shenzhen, China | 1 | 3% | 1 | JGene Biotechnology |
| 15 | Vinno Capital | Venture capital firm | Shenzhen, China | 1 | 3% | 1 | JGene Biotechnology |
Table 3. Biotech startups that raised Series A in Shenzhen, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 26 | 76% | $494.7M |
| Artificial intelligence | 6 | 18% | $269.4M |
| Software | 6 | 18% | $269.4M |
| Hardware | 1 | 3% | $16.0M |
| Energy | 1 | 3% |
Table 4. Biotech startups that raised Series A in Shenzhen, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 34 | 100% | $14.4M |
Table 5. Biotech startups that raised Series A in Shenzhen, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 9% | $30.0M |
| August 2026 | 2 | 18% | $14.8M |
| June 2026 | 1 | 9% | $14.7M |
| May 2026 | 1 | 9% | $14.7M |
| February 2026 | 1 | 9% | $14.4M |
| January 2026 | 3 | 27% | |
| December 2025 | 1 | 9% | |
| November 2025 | 1 | 9% |
Table 6. Biotech startups that raised Series A in Shenzhen, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 9 | 26% | $88.6M |
| 2025 | 6 | 18% | $21.0M |
| 2024 | 6 | 18% | $16.5M |
| 2023 | 3 | 9% | $14.0M |
| 2022 | 2 | 6% | $15.7M |
| 2021 | 1 | 3% | $15.5M |
Table 7. Biotech startups that raised Series A in Shenzhen, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 9% |
| 2020 to 2022 | 11 | 32% |
| 2015 to 2019 | 14 | 41% |
| 2010 to 2014 | 4 | 12% |
| Before 2010 | 2 | 6% |
Table 8. Biotech startups that raised Series A in Shenzhen, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 3 | 11% |
| 11 to 50 | 18 | 64% |
| 51 to 100 | 4 | 14% |
| 101 to 250 | 2 | 7% |
| 501 to 1,000 | 1 | 4% |
Table 9. Biotech startups that raised Series A in Shenzhen, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series A and its headquarters is in Shenzhen, China. On 16 November 2026 that is 34 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 3 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 34 rows: 15 have no round amount, 0 no city and 12 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Shenzhen, China whose last round is Series A are on the list?
- 34, in the file dated 16 November 2026. 11 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 34 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.